Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus with reduced tacrolimus in living donor liver transplant
NCT01888432Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2013
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of everolimus in Liver transplant rejection, sponsored by Novartis. Started Sep 2013; status: completed.
02
Drugs
everolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT01888432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01888432.